Immune Response to PSF in Idiopathic vs Neuromuscular Scoliosis
Part of paid clinical trials in Columbus, Ohio.
- Sponsor
- Ambrish Patel
- Study ID
- NCT07734467
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Idiopathic Scoliosis
- Neuromuscular Scoliosis
- Posterior Spinal Fusion
Eligibility Criteria
- Sex
- ALL
- Age
- 0 Years - 99 Years
- Healthy Volunteers
- Not accepted
Interventions
- Serum blood samples for serum biomarkers of immune response — DIAGNOSTIC_TESTPreoperative and postoperative blood samples using biomarkers to evaluate immune response.
Study Details
The objective of this study is to evaluate the immune response to posterior spinal fusion (PSF) in patients with neuromuscular scoliosis, comparing patients with idiopathic scoliosis who undergo the same procedure. This will be accomplished using serum biomarkers of immune response. Anecdotally, it appears that patients with neuromuscular scoliosis have more fluid resuscitation needs compared to patients with idiopathic scoliosis. The proposed hypothesis of this observation is that patients with neuromuscular scoliosis have a more profound immune response compared to patients with idiopathic scoliosis, which leads to a more robust systematic inflammatory response syndrome.
Key Dates
- First listed
- Jul 29, 2026
- Start date
- Oct 31, 2026
- Status verified
- Jul 2026
- Primary completion
- Jun 30, 2029
- Completion
- Dec 31, 2029
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- SINGLE_GROUP
- Primary purpose
- OTHER
Arms
- Active Comparator: Neuromuscular scoliosisPatients with neuromuscular scoliosis undergoing posterior spinal fusion
- Active Comparator: Idiopathic scoliosisPatients with idiopathic scoliosis undergoing posterior spinal fusion
Primary Outcome Measure
Immune response to posterior spinal fusion in patients with neuromuscular scoliosis compared to patients with idiopathic scoliosis [ Time Frame: From enrollment to approximately one hour after surgery completion. ]
Central Contacts
- Catherine Roth614-722-2997
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Nationwide Children's Hospital | Columbus | Ohio | 43205 | Ambrish Patel, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Columbus, OH
Related Studies
- Advanced SPinal Innovations With Robotics and Enabling Technology RegistryRecruiting · Boston Children's Hospital · Los Angeles, California
- Evaluation of Analgesia for Spine Fusion Elective Surgery in ChildrenPHASE3 · Recruiting · Senthil Sadhasivam · Cincinnati, Ohio
- Postoperative Steroid Use in Adolescent Idiopathic Scoliosis and Neuromuscular Scoliosis PatientsPHASE4 · Not Yet Recruiting · Children's Hospital Los Angeles · Los Angeles, California
- Kids With Iron Deficiency and ScoliosisRecruiting · Columbia University · New York, New York